China Pharma Holdings (CPHI) Capital Expenditures (2010 - 2025)
China Pharma Holdings (CPHI) reported Capital Expenditures of $454.0 for Q4 2025, down 97.68% on a YoY basis from $19545.0 in Q4 2024, and down 25.7% quarter-over-quarter from $611.0 in Q3 2025.
China Pharma Holdings (CPHI) Capital Expenditures (2010 - 2025) Analysis & Trends
China Pharma Holdings has reported Capital Expenditures for 16 years, with the latest figure at $454.0 in Q4 2025.
- For the quarter ending Q4 2025, Capital Expenditures fell 97.68% year-over-year to $454.0; the trailing twelve-month figure through Dec 2025 stood at $59324.0 (down 27.92% YoY), and the FY2025 full-year result was $59324.0, up 54.45% from the prior year.
- Capital Expenditures for Q4 2025 stood at $454.0, down from $611.0 in the prior quarter.
- The five-year high for Capital Expenditures was $415977.0 in Q3 2021, with the low at -$55964.0 in Q1 2023.
- Historically, Capital Expenditures has averaged $56635.2 across 5 years, with a median of $2959.0 in 2022.
- Annual changes were most pronounced in 2023 — Capital Expenditures plunged 4123.29% — and 2024, when it soared 331.74%.
- China Pharma Holdings' Capital Expenditures stood at $7056.0 in 2021, then tumbled by 486.45% to -$27268.0 in 2022, then soared by 116.6% to $4527.0 in 2023, then jumped by 331.74% to $19545.0 in 2024, then slumped by 97.68% to $454.0 in 2025.
- The last three Capital Expenditures figures came in at $454.0 (Q4 2025), $611.0 (Q3 2025), and -$65.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 8.83 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.04 Mn |
| 10 | China Pharma Holdings | 18.87 Mn | 18.70 Mn | 285,487.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 454.00 |
| Dec 31, 2025 | 454.00 |
| Sep 30, 2025 | 611.00 |
| Sep 30, 2025 | 611.00 |
| Jun 30, 2025 | -65.00 |
| Jun 30, 2025 | -65.00 |
| Mar 31, 2025 | 58,324.00 |
| Mar 31, 2025 | 58,324.00 |
| Dec 31, 2024 | 19,545.00 |
| Dec 31, 2024 | 19,545.00 |
| Sep 30, 2024 | -9,220.00 |
| Sep 30, 2024 | -9,220.00 |
| Dec 31, 2023 | 4,527.00 |
| Dec 31, 2023 | 4,527.00 |
| Sep 30, 2023 | 67,455.00 |
| Sep 30, 2023 | 67,455.00 |
| Jun 30, 2023 | -4,501.00 |
| Jun 30, 2023 | -4,501.00 |
| Mar 31, 2023 | -55,964.00 |
| Mar 31, 2023 | -55,964.00 |